069620.KS

Daewoong pharmaceutical Co.,Ltd [069620.KS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

069620.KS Stock Summary

Top 10 Correlated ETFs

069620.KS

Top 10 Correlated Stocks

069620.KS

In the News

069620.KS Financial details

Company Rating
-
Market Cap
1319.77B
Income
121.74B
Revenue
1375.33B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.68K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
29.39
Forward P/E
-
PEG
1.65
P/S
0.96
P/B
1.85
P/C
-
P/FCF
73.49
Quick Ratio
-
Current Ratio
0.91
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
10.62K
EPS next Y
-
EPS next Q
-
EPS this Y
179.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
37.96%
Revenue last 5Y
4.32%
Revenue Q/Q
6.14%
EPS Q/Q
323.71%
-
-
-
-
SMA20
-2.62%
SMA50
14.89%
SMA100
7.13%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
7%
ROC
0.1%
Gross Margin
50%
Oper. Margin
8%
Profit Margin
3%
Payout
2%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
88300.0-127600.0
52W High
+24.45%
52W Low
+79.84%
RSI
46
Rel Volume
3.67
Avg Volume
31.05K
Volume
113.93K
Perf Week
5.03%
Perf Month
14.82%
Perf Quarter
25.24%
Perf Half Y
25.63%
-
-
-
-
Beta
0.896
-
-
Volatility
5025.49%, 8246.38%
Prev Close
9.29%
Price
158800
Change
9.07%

Something similar

Top by Market Cap
DHR-PB
AMZN
ABEC.DE
GOOG
BRYN.DE
Top Correlated ETFs
GBUG
GOEX
JNUG
GOAU
MATH
Top Correlated Stocks
003090.KS
0IIW.L
ETSY
SNBN.SW
CDTI
Similar Market Cap
009970.KS
SIBN.ME
237690.KQ
3088.T
1088.HK

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 31.05K
  • Market Capitalization 1319.77B
  • Employee 1.68K
  • CEO Mr. Chang-Jae Lee
  • Headquarters Seoul,KR
  • IPO Date 2005-09-29
  • Website https://www.daewoong.com

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.